RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2023

Feb 14, 2023

SEC Form 4/A — Form 4/A

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2023-02-09

Reporting Person: Cramer Pamela J. (Chief Human Resources Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-09	Common Stock	S	843	$27.51	Disposed	6142	Direct

Footnotes

F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.